The recent failure of the antisense oligonucleotide-based trials against C9orf72 mutations, which represent the major genetic cause of ALS and FTD, has highlighted the need for a better understanding of the pathological features linked to this gene. The gene discussed is C9orf72; the disease is frontotemporal dementia.